157 E 32nd St. New York, NY 10016 212-689-6791

Clinical Trials at MHOA


Now enrolling patients on a phase 2/3 clinical study for the treatment of AML patients with FLT3 mutations who are…

Read More


Now enrolling patients for a phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the FLT3 Inhibitor Gilteritinib (ASP2215)…

Read More


Now enrolling patients for the InformCLL Registry, which is to characterize and describe treatment patterns for those initiating treatment with…

Read More

Mantle Cell Lymphoma

Now¬†enrolling patients in a phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of…

Read More

Multiple Myeloma

Now enrolling patients for a PD-1 Immunotherapy trial at MHOA in New York City

Read More